SCHEMBL3976578

SCHEMBL3976578

CCCN(CCC)c1ccc2c(c1)Cc1cc(NC(=O)OC(C)(C)C)ccc1-2

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1I3 Q14994 5/20 0.48
RAB9A P51151 2/20 0.48
NPC1 O15118 1/20 0.46
KMT2A Q03164 1/20 0.42
POLB P06746 1/20 0.41
CYP1A2 P05177 1/20 0.41
ADRA2A P08913 1/20 0.41
MAOA P21397 1/20 0.41
SLC6A2 P23975 1/20 0.41
HTR2C P28335 1/20 0.41
SLC6A4 P31645 1/20 0.41
HTR2B P41595 1/20 0.41
MAPT P10636 2/20 0.40
MMP8 P22894 4/20 0.39
MMP3 P08254 2/20 0.39
GHSR Q92847 1/20 0.39
CYP17A1 P05093 1/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
GAA P10253 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1114945 0.84 RAB9A (0.56) NR1I3RAB9ANPC1KMT2APOLB
SCHEMBL3979949 0.84 RAB9A (0.52) NR1I3RAB9ANPC1KMT2APOLB
SCHEMBL1206292 0.83 MAPT (0.54) NR1I3RAB9ANPC1KMT2AMAPT
SCHEMBL3978151 0.82 RAB9A (0.67) NR1I3RAB9ANPC1KMT2APOLB
SCHEMBL4984937 0.82 RAB9A (0.50) NR1I3RAB9ANPC1KMT2APOLB
SCHEMBL3977433 0.80 RAB9A (0.42) NR1I3RAB9ANPC1KMT2APOLB
SCHEMBL13612901 0.78 RAB9A (0.50) NR1I3RAB9ANPC1KMT2APOLB
SCHEMBL3005279 0.78 CYP1A2 (0.66) RAB9ANPC1KMT2ACYP1A2ADRA2A
SCHEMBL3977947 0.78 RAB9A (0.47) RAB9ANPC1KMT2APOLBCYP1A2
SCHEMBL3978167 0.77 RAB9A (0.52) NR1I3RAB9ANPC1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2056810-A2 THIOUREA COMPOUNDS National Health Research Institutes (TW) 2009-05-13 EP disclosed
US-20080113975-A1 THIOUREA COMPOUNDS NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2008-05-15 US disclosed
US-20080113975-A1 THIOUREA COMPOUNDS NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2008-05-15 US disclosed
US-20080113975-A1 THIOUREA COMPOUNDS NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2008-05-15 US disclosed
US-20080096875-A1 THIOUREA COMPOUNDS NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2008-04-24 US disclosed
US-20080096875-A1 THIOUREA COMPOUNDS NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2008-04-24 US disclosed
US-20080096875-A1 THIOUREA COMPOUNDS NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2008-04-24 US disclosed
WO-2008022204-A2 THIOUREA COMPOUNDS NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2008-02-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080096875-A1 THIOUREA COMPOUNDS TPMT, HAVCR2, ETV6 NR1I3 2222/4885RAB9A 2434/4885NPC1 1677/4885
US-20080113975-A1 THIOUREA COMPOUNDS TPMT, HAVCR2, EIF2AK2 NR1I3 1453/4885RAB9A 2430/4885NPC1 1372/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.